Literature DB >> 2006235

Study of the P300 and cerebral maps in subjects with multi-infarct dementia treated with cytidine.

V Gallai1, G Mazzotta, C Firenze, S Montesi, F Del Gatto.   

Abstract

A study of event-related P300 potential and cerebral EEG maps was performed in 20 patients affected by multi-infarct dementia (MID): 10 subjects were treated with placebo and 10 with cytidine. The trial was divided into three intervals. The patients, after a period of washout, were evaluated throughout the course of the trial by electrophysiological examination performed at baseline, after 90 min from the first IV injection, again after 30 days of IM therapy, and finally after 60 days of continued IM therapy. In the group treated with cytidine, the findings relevant to the study of the P300 showed a significant decrease in latency values compared to baseline (P less than 0.05 ANOVA) and an improvement. though not significant, in the amplitude values. Calculation of the mean relative power of EEG values showed a significant decrease in delta activity and an increase in alpha activity. In the subjects treated with placebo, no statistically significant variation was found in either P300 or EEG map recordings. On the basis of these investigations it has been demonstrated that the variations in the registrations can be correlated to the improved neuronal activity following treatment with cytidine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2006235     DOI: 10.1007/bf02244066

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  Nucleosides and nucleotides: past, present, and future.

Authors:  R K Robins
Journal:  Ann N Y Acad Sci       Date:  1975-08-08       Impact factor: 5.691

3.  [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine].

Authors:  F Cosmi; L Caresia; G Panebianco
Journal:  Clin Ter       Date:  1986-02-15

4.  Effects of short-term administration of cytidine, uridine and levoglutamine, alone or in combination, on the cerebral electrical activity of patients with chronic cerebrovascular disease.

Authors:  V Manna; N Martucci
Journal:  Int J Clin Pharmacol Res       Date:  1988

5.  Multi-infarct dementia. A cause of mental deterioration in the elderly.

Authors:  V C Hachinski; N A Lassen; J Marshall
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

Review 6.  Electrophysiology of cognitive processing.

Authors:  S A Hillyard; M Kutas
Journal:  Annu Rev Psychol       Date:  1983       Impact factor: 24.137

7.  The influence of cytidine on the endogenous pool of CDP-choline, CDP-ethanolamine, and CMP of the rat brain.

Authors:  G Trovarelli; C A Palmerini; A Floridi; G L Piccinin; G Porcellati
Journal:  Neurochem Res       Date:  1984-01       Impact factor: 3.996

8.  Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study.

Authors:  A Agnoli; N Martucci; V Manna; L Conti; M Fioravanti
Journal:  Clin Neuropharmacol       Date:  1983       Impact factor: 1.592

9.  Diagnostic evaluation of degenerative and vascular dementia.

Authors:  C Loeb; C Gandolfo
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

10.  Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type.

Authors:  F H Duffy; M S Albert; G McAnulty
Journal:  Ann Neurol       Date:  1984-10       Impact factor: 10.422

View more
  1 in total

1.  Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy.

Authors:  S M Babb; K E Appelmans; P F Renshaw; R J Wurtman; B M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.